The overexpression of SFRS9 inhibits CRC cell death and lipid peroxidation induced by erastin and sorafenib, and the inhibitory effects of ferroptosis are mediated by decreased GPX4 levels [39]. The gene discussed is GPX4; the disease is colorectal carcinoma.